| P50 | author | Stefan H Hohnloser | Q110902934 |
| | Derek Exner | Q123189909 |
| P2093 | author name string | Tuomo Nieminen | |
| | David S Rosenbaum | |
| | Sanjiv M Narayan | |
| | Marek Malik | |
| | Richard L Verrier | |
| | Takanori Ikeda | |
| | Nabil El-Sherif | |
| | Thomas Klingenheben | |
| | Juan Pablo Martínez | |
| P2860 | cites work | Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction | Q29039536 |
| | Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction | Q29040770 |
| | T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test | Q29041029 |
| | Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy: A Solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Conundrum | Q29308392 |
| | Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop | Q30433543 |
| | Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association | Q30434464 |
| | Demonstration of the proarrhythmic preconditioning of single premature extrastimuli by use of the magnitude, phase, and distribution of repolarization alternans | Q30650497 |
| | T wave alternans does not assess arrhythmic risk in patients with Brugada syndrome. | Q33151283 |
| | Spontaneous T wave alternans in a patient with Brugada syndrome--responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing | Q33152355 |
| | Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? | Q33153551 |
| | Microvolt t-wave alternans with exercise in pediatrics and congenital heart disease: limitations and predictive value | Q33154119 |
| | Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. | Q33155317 |
| | Influence of QRS duration on the prognostic value of T wave alternans | Q74730709 |
| | Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long-QT syndrome: tridimensional analysis of the kinetics of cardiac repolarization | Q77315003 |
| | T-wave alternans as a predictor for sudden cardiac death after myocardial infarction | Q77456447 |
| | Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy | Q77480649 |
| | Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction | Q78375753 |
| | Progressive increases in complexity of T-wave oscillations herald ischemia-induced ventricular fibrillation | Q78390793 |
| | Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study | Q79425794 |
| | Endocardial and epicardial repolarization alternans in human cardiomyopathy: evidence for spatiotemporal heterogeneity and correlation with body surface T-wave alternans | Q79615285 |
| | Noninvasive risk assessment early after a myocardial infarction the REFINE study | Q80167370 |
| | Effect of bundle branch block on microvolt T-wave alternans and electrophysiologic testing in patients with ischemic cardiomyopathy | Q80544620 |
| | Spinal cord stimulation affects T-wave alternans in patients with ischaemic cardiomyopathy: a pilot study | Q80868909 |
| | Dichotomizing continuous predictors in multiple regression: a bad idea | Q81336757 |
| | Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest | Q81414753 |
| | Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failure | Q81831322 |
| | American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the A | Q82010700 |
| | Importance of regional specificity of T-wave alternans in assessing risk for cardiovascular mortality and sudden cardiac death during routine exercise testing | Q82345413 |
| | Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model | Q82540123 |
| | The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention | Q83300940 |
| | Time-domain T-wave alternans measured from Holter electrocardiograms predicts cardiac mortality in patients with left ventricular dysfunction: a prospective study | Q83404815 |
| | Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis | Q84043221 |
| | Ambulatory ECG-based T-wave alternans and heart rate turbulence predict high risk of arrhythmic events in patients with old myocardial infarction | Q84742429 |
| | Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome | Q33155579 |
| | Intracardiac alternans compared to surface T-wave alternans as a predictor of ventricular arrhythmias in humans | Q33156413 |
| | The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease | Q33213147 |
| | Association of Holter-based measures including T-wave alternans with risk of sudden cardiac death in the community-dwelling elderly: the Cardiovascular Health Study | Q33798688 |
| | Rate-dependent action potential alternans in human heart failure implicates abnormal intracellular calcium handling | Q34021051 |
| | Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation | Q34100661 |
| | Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 |
| | Sudden death due to cardiac arrhythmias | Q34496008 |
| | Upsurge in T-wave alternans and nonalternating repolarization instability precedes spontaneous initiation of ventricular tachyarrhythmias in humans. | Q34539968 |
| | Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials | Q34550514 |
| | Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators | Q34581868 |
| | Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarcti | Q34599944 |
| | Interpretation and classification of microvolt T wave alternans tests | Q34657147 |
| | Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis | Q36181613 |
| | T-wave alternans and the susceptibility to ventricular arrhythmias | Q36368212 |
| | Mechanisms of calcium transient and action potential alternans in cardiac cells and tissues | Q36977081 |
| | Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling | Q37037251 |
| | Basis for sudden cardiac death prediction by T-wave alternans from an integrative physiology perspective | Q37167055 |
| | Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. | Q37304888 |
| | Impact of sleep on arrhythmogenesis | Q37349197 |
| | Explaining the clinical manifestations of T wave alternans in patients at risk for sudden cardiac death | Q37377073 |
| | Heart failure enhances susceptibility to arrhythmogenic cardiac alternans | Q37393007 |
| | Risk stratification for sudden death in patients with coronary artery disease | Q37494978 |
| | Noninvasive risk stratification after myocardial infarction: rationale, current evidence and the need for definitive trials | Q37517247 |
| | Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. | Q37635420 |
| | Anger-induced T-wave alternans predicts future ventricular arrhythmias in patients with implantable cardioverter-defibrillators | Q37691447 |
| | Microvolt T-wave alternans, peak oxygen consumption, and outcome in patients with severely impaired left ventricular systolic function. | Q37727121 |
| | T-wave alternans as a therapeutic marker for antiarrhythmic agents | Q37765792 |
| | Alternans and arrhythmias: from cell to heart | Q37826594 |
| | Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study | Q40548860 |
| | Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy | Q40665980 |
| | Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study | Q40774059 |
| | Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy | Q41773480 |
| | Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans | Q42636318 |
| | Assessment of microvolt T-wave alternans in high-risk patients with the congenital long-QT syndrome. | Q43694805 |
| | Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study | Q43818876 |
| | Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias: a prospective study using atrial pacing | Q43965330 |
| | Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. | Q44025163 |
| | Evidence regarding clinical use of microvolt T-wave alternans | Q44150063 |
| | Predicting arrhythmia-free survival using spectral and modified-moving average analyses of T-wave alternans | Q44388270 |
| | High prevalence of cardiac autonomic dysfunction and T-wave alternans in dialysis patients | Q44577936 |
| | Relation between Microvolt-Level T-Wave Alternans and cardiac sympathetic nervous system abnormality using iodine-123 metaiodobenzylguanidine imaging in patients with Idiopathic Dilated cardiomyopathy | Q44616026 |
| | Effects of selective autonomic blockade on T-wave alternans in humans | Q45712793 |
| | Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study | Q46296932 |
| | Usefulness of microvolt T-wave alternans to predict outcomes in patients with ischemic cardiomyopathy beyond one year | Q47444514 |
| | Sleep apnoea induces cardiac electrical instability assessed by T-wave alternans in patients with congestive heart failure | Q48383713 |
| | Quantification of ischaemia induced vulnerability by precordial T wave alternans analysis in dog and human | Q49144098 |
| | Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. | Q50763646 |
| | Tracking cardiac electrical instability by computing interlead heterogeneity of T-wave morphology. | Q50763868 |
| | Dynamic tracking of cardiac vulnerability by complex demodulation of the T wave. | Q50796726 |
| | Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. | Q50871374 |
| | Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. | Q51088140 |
| | ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo | Q51137889 |
| | Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. | Q51207701 |
| | Characterization of repolarization alternans during ischemia: time-course and spatial analysis. | Q51230595 |
| | Methodological principles of T wave alternans analysis: a unified framework. | Q51504307 |
| | Prediction of sudden cardiac death in patients after acute myocardial infarction using T-wave alternans: a prospective study. | Q51531920 |
| | Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. | Q51700685 |
| | Enhanced predictive power of quantitative TWA during routine exercise testing in the Finnish Cardiovascular Study. | Q51853647 |
| | "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. | Q51932482 |
| | Mechanism of discordant T wave alternans in the in vivo heart. | Q52012232 |
| | Combined assessment of heart rate recovery and T-wave alternans during routine exercise testing improves prediction of total and cardiovascular mortality: the Finnish Cardiovascular Study. | Q53793465 |
| | Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both | Q57396339 |
| | Post-Exercise Assessment of Cardiac Repolarization Alternans in Patients With Coronary Artery Disease Using the Modified Moving Average Method | Q57417461 |
| | A Multilead Scheme Based on Periodic Component Analysis for T-Wave Alternans Analysis in the ECG | Q57559995 |
| | Prognostic Significance of Risk Stratifiers of Mortality, Including T Wave Alternans, After Acute Myocardial Infarction: Results of a Prospective Follow-Up Study | Q57914811 |
| | Guidelines for the interpretation of the neonatal electrocardiogram | Q58010911 |
| | Electrocardiographic Prediction of Abnormal Genotype in Congenital Long QT Syndrome: Experience in 101 Related Family Members | Q58010947 |
| | Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction | Q58011025 |
| | Electrical alternation of the T-wave: Clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome | Q58011829 |
| | Temporal Variations in Microvolt T-Wave Alternans Testing after Acute Myocardial Infarction | Q63508791 |
| | Electrical alternans and cardiac electrical instability | Q68248564 |
| | Significance of discordant ST alternans in ventricular fibrillation | Q68606416 |
| | Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem | Q71410386 |
| | Electrical alternans and vulnerability to ventricular arrhythmias | Q72684261 |
| | A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification | Q73321670 |
| | Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study | Q73562122 |
| | T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation | Q73681965 |
| | Optimal target heart rate for exercise-induced T-wave alternans | Q73828571 |
| | Incidence of T wave alternation after acute myocardial infarction and correlation with other prognostic parameters: results of a prospective study | Q74188131 |
| | Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure | Q74252421 |
| | Microvolt T wave alternans in human cardiac hypertrophy: electrical instability and abnormal myocardial arrangement | Q74254384 |
| | Influence of heart rate and sympathetic stimulation on arrhythmogenic T wave alternans | Q74332496 |
| | Short-term reproducibility of T wave alternans measurement | Q74516288 |
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microvolt | Q1916026 |
| P304 | page(s) | 1309-1324 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology | |
| P478 | volume | 58 | |